Breaking News Headlines Today

News from pharmafile.com

See all of pharmafile.com news coverage in one place. Discover how pharmafile.com’s media bias informs their coverage and compare with thousands of other news outlets.

Overall, we’ve indexed 190 stories from pharmafile.com over the past 3 months.

Ground News rates pharmafile.com’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

pharmafile.com’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about pharmafile.com

Where is pharmafile.com located?pharmafile.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top pharmafile.com News

Eli Lilly · United States

Eli Lilly’s obesity pill led to around 12% weight loss in closely watched late-stage trial, paving way for approval

66% Center coverage: 42 sources

See the Story

New York City · New York

Medidata Accelerates Business Transformation with Lisa Moneymaker as Chief Strategy Officer

67% Left coverage: 6 sources

Lisa Moneymaker will lead the Strategy organization, reinforcing Medidata's commitment to long-term growth in a rapidly evolving market...See the Story

Medical · Castilla Y León

Sandoz Secures 10-Year Green Energy Deal for European Operations

Sandoz, the Swiss pharmaceutical giant specializing in generic and biosimilar medicines, has taken a significant stride in its decarbonization journey by inking a 10-year virtual Power Purchase Agreement (PPA) with Elawan Energy. This strategic move is set to cover nearly 90% of Sandoz’s electricity demand in Europe, a region that constitutes the bulk of the company’s global operations. Source See the Story

CuraCell Gains German Approval for Clinical Trial Application of CC-38

CuraCell Holding’s CTA has received approval from Germany's Paul-Ehrlich-Institut (PEI) to begin a Phase I/IIa trial of CC-38.The post CuraCell gains German approval for clinical trial application of CC-38 appeared first on Clinical Trials Arena.Germany · Germany See the Story

Enzybel Pharma 2 and Deebio partner to address pancrelipase shortages - Pharmafile

Enzybel Pharma 2, part of European distributor Natix, has formed an alliance with Chinese enzyme manufacturer Deebio to help alleviate the global shortage of high-activity pancrelipase (pancreatin). The partnership will focus on producing a highly purified, standardised form of the active pharmaceutical ingredient (API), used in the treatment of pancreatic insufficiency. To meet European and […] The post Enzybel Pharma 2 and Deebio partner to ad…China · China Read Article

NICE recommends Benralizumab for Rare Form of Vasculitis - Pharmafile

The National Institute for Health and Care Excellence (NICE) has recommended AstraZeneca’s benralizumab (Fasenra) as an add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA). This marks the first NHS-funded biologic treatment option for eligible patients in England, with interim funding allowing immediate access. The recommendation is based on results […] The post NICE recommends Be…England · England Read Article

Novartis candidate for Sjögren’s disease presents positive results - Pharmafile

Novartis has reported positive results from two phase 3 clinical trials – NEPTUNUS-1 and NEPTUNUS-2 – evaluating ianalumab in adults with active Sjögren’s disease. Both trials met their primary endpoint, showing statistically significant improvements in systemic disease activity compared with placebo, measured by the EULAR Sjögren’s syndrome disease activity index. Sjögren’s disease is a chronic […] The post Novartis candidate for Sjögren’s dise…Read Article

KIFFIK Biomedical expands leadership team with two executive appointments - Pharmafile

KIFFIK Biomedical has strengthened its leadership team with the appointments of Rene Veloso as chief investment officer and Reginald Swift as fractional chief scientific officer. The US-based diagnostics company specialises in interstitial fluid-based monitoring, a needle-free technology for real-time disease detection and health tracking. This method offers a non-invasive alternative to biomarker detection, with applications […] The post KIFFIK…United States · United States Read Article

Sanofi’s treatment granted orphan designation for rare chronic inflammatory condition - Pharmafile

The European Medicines Agency has granted orphan designation to Sanofi’s investigational Bruton’s tyrosine kinase (BTK) inhibitor, rilzabrutinib, for the treatment of IgG4-related disease (IgG4-RD), a chronic inflammatory condition. The designation is given to therapies targeting rare, serious or debilitating conditions affecting no more than five in 10,000 people in the EU. The decision follows positive […] The post Sanofi’s treatment granted o…Read Article

PhotoPharmics expands Parkinson’s Trial into further US states - Pharmafile

US-based PhotoPharmics, has expanded enrollment in its Light for PD clinical trial beyond its original 300 participants, opening new sites in Illinois, Florida and Arizona. These states were chosen due to their higher populations of retirees and people living with Parkinson’s disease. The Light for PD study is assessing the safety and effectiveness of Celeste, […] The post PhotoPharmics expands Parkinson’s Trial into further US states appeared f…Florida, United States · Florida Read Article

Eyestem secures $10m to advance cell therapy for advanced eye disease - Pharmafile

Indian cell therapy company, Eyestem Research, has raised $10m in a funding round to support development of its investigational retinal pigment cell therapy, Eyecyte-RPE, for geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The funding will allow for the completion of an ongoing phase 2 clinical trial in India and preparations for an […] The post Eyestem secures $10m to advance cell therapy for advanced eye diseas…India · India Read Article

News from pharmafile.com

News from pharmafile.com

Information about pharmafile.com

Media Bias Ratings

Factuality

Ownership

Top pharmafile.com News

Eli Lilly’s obesity pill led to around 12% weight loss in closely watched late-stage trial, paving way for approval

Medidata Accelerates Business Transformation with Lisa Moneymaker as Chief Strategy Officer

Sandoz Secures 10-Year Green Energy Deal for European Operations

CuraCell Gains German Approval for Clinical Trial Application of CC-38

Enzybel Pharma 2 and Deebio partner to address pancrelipase shortages - Pharmafile

NICE recommends Benralizumab for Rare Form of Vasculitis - Pharmafile

Novartis candidate for Sjögren’s disease presents positive results - Pharmafile

KIFFIK Biomedical expands leadership team with two executive appointments - Pharmafile

Sanofi’s treatment granted orphan designation for rare chronic inflammatory condition - Pharmafile

PhotoPharmics expands Parkinson’s Trial into further US states - Pharmafile

Eyestem secures $10m to advance cell therapy for advanced eye disease - Pharmafile

Similar News Topics

Topics Most Covered by pharmafile.com

Sources Covering Similar Topics

Breaking News Topics Related to pharmafile.com

Information about pharmafile.com

Media Bias Ratings

Factuality

Ownership

CuraCell Gains German Approval for Clinical Trial Application of CC-38

Enzybel Pharma 2 and Deebio partner to address pancrelipase shortages - Pharmafile

NICE recommends Benralizumab for Rare Form of Vasculitis - Pharmafile

Novartis candidate for Sjögren’s disease presents positive results - Pharmafile

KIFFIK Biomedical expands leadership team with two executive appointments - Pharmafile

Sanofi’s treatment granted orphan designation for rare chronic inflammatory condition - Pharmafile

PhotoPharmics expands Parkinson’s Trial into further US states - Pharmafile

Eyestem secures $10m to advance cell therapy for advanced eye disease - Pharmafile